Cargando…

Who gets prescriptions for proton pump inhibitors and why? A drug-utilization study with claims data in Bavaria, Germany, 2010–2018

PURPOSE: The German annual drug prescription-report has indicated overuse of proton pump inhibitors (PPIs) for many years; however, little was known about the characteristics of people using PPIs. This study aimed to provide comprehensive utilization data and describe frequencies of potential on- an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rückert-Eheberg, Ina-Maria, Nolde, Michael, Ahn, Nayeon, Tauscher, Martin, Gerlach, Roman, Güntner, Florian, Günter, Alexander, Meisinger, Christa, Linseisen, Jakob, Amann, Ute, Baumeister, Sebastian-Edgar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Pharmacoepidemiology and Prescription
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927002/ https://www.ncbi.nlm.nih.gov/pubmed/34877614 http://dx.doi.org/10.1007/s00228-021-03257-z

Ejemplares similares

Lack of association between proton pump inhibitor use and brain aging: a cross-sectional study
por: Ahn, Nayeon, et al.
Publicado: (2021)

Pharmacoepidemiology resources in Ireland—an introduction to pharmacy claims data
por: Sinnott, Sarah-Jo, et al.
Publicado: (2017)

Use of rivaroxaban in Germany: a database drug utilization study of a drug started in hospital
por: Jobski, Kathrin, et al.
Publicado: (2014)

Defining antimicrobial prescribing quality indicators: what is a new prescription?
por: Boesten, Jos, et al.
Publicado: (2010)

Hospitalisations related to benzodiazepine, Z-drug, and opioid treatment in Italy: a claim on the risks associated with inappropriate use
por: Mattioli, Irene, et al.
Publicado: (2022)

Prescription of antibacterial agents for acute upper respiratory tract infections in Beijing, 2010–2012
por: Wu, Yiqun, et al.
Publicado: (2015)

The 10-year trend in drug prescriptions for attention-deficit/hyperactivity disorder (ADHD) in Germany
por: Grimmsmann, Thomas, et al.
Publicado: (2020)

Identification of Dutch children diagnosed with atopic diseases using prescription data: a validation study
por: Mulder, B, et al.
Publicado: (2015)

The interplay of context factors in hypnotic and sedative prescription in primary and secondary care—a qualitative study
por: Weiß, Vivien, et al.
Publicado: (2018)

Medication as a risk factor for hospitalization due to heart failure and shock: a series of case-crossover studies in Swiss claims data
por: Jödicke, Annika M., et al.
Publicado: (2020)

Prescription analgesia and adjuvant use by pain severity at admission among nursing home residents with non-malignant pain
por: Lapane, Kate L., et al.
Publicado: (2020)

Prior outpatient antibiotic use as predictor for microbial aetiology of community-acquired pneumonia: hospital-based study
por: van de Garde, Ewoudt MW, et al.
Publicado: (2007)

Medication administered to children from 0 to 7.5 years in the Avon Longitudinal Study of Parents and Children (ALSPAC)
por: Headley, J., et al.
Publicado: (2007)

How useful are prescribing indicators based on the DU90% method to distinguish the quality of prescribing between pharmacotherapy audit meetings with different levels of functioning?
por: Teichert, Martina, et al.
Publicado: (2007)

Evaluation of patients’ experiences with antidepressants reported by means of a medicine reporting system
por: van Geffen, E. C. G., et al.
Publicado: (2007)

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands
por: van Hunsel, Florence, et al.
Publicado: (2010)

Frequency of laboratory measurement and hyperkalaemia in hospitalised patients using serum potassium concentration increasing drugs
por: Uijtendaal, Esther V., et al.
Publicado: (2011)

Regulatory scientific advice in drug development: does company size make a difference?
por: Putzeist, Michelle, et al.
Publicado: (2010)

Discrepancies between prescribed and defined daily doses: a matter of patients or drug classes?
por: Grimmsmann, Thomas, et al.
Publicado: (2011)

The use of driving impairing medicines: a European survey
por: Ravera, Silvia, et al.
Publicado: (2009)

Ten years after the Dutch public health campaign on folic acid: the continuing challenge
por: de Walle, Hermien E. K., et al.
Publicado: (2008)

The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports
por: Derijks, Hieronymus J., et al.
Publicado: (2008)

Predictors of orphan drug approval in the European Union
por: Heemstra, Harald E., et al.
Publicado: (2008)

Pharmacovigilance in children in Camagüey Province, Cuba
por: Bárzaga Arencibia, Z., et al.
Publicado: (2012)

Effects of codeine on pregnancy outcome: results from a large population-based cohort study
por: Nezvalová-Henriksen, Kateřina, et al.
Publicado: (2011)

Dopamine agonists and ischemic complications in Parkinson’s disease: a nested case–control study
por: Arbouw, Maurits E. L., et al.
Publicado: (2011)

Systematic review of safety in paediatric drug trials published in 2007
por: Nor Aripin, Khairun Nain Bin, et al.
Publicado: (2011)

Appropriateness of treatment recommendations for PPI in hospital discharge letters
por: Ahrens, Dirk, et al.
Publicado: (2010)

The use of opioids at the end of life: knowledge level of pharmacists and cooperation with physicians
por: Borgsteede, Sander D., et al.
Publicado: (2010)

Pattern of asthma medication use among children from a large urban center in Brazil
por: Santos, Djanilson Barbosa, et al.
Publicado: (2011)

Do medical students copy the drug treatment choices of their teachers or do they think for themselves?
por: Tichelaar, J., et al.
Publicado: (2009)

Unintended consequences of reducing QT-alert overload in a computerized physician order entry system
por: van der Sijs, Heleen, et al.
Publicado: (2009)

Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson’s disease
por: Arbouw, Maurits E. L., et al.
Publicado: (2009)

Medication errors in the Middle East countries: A systematic review of the literature
por: Alsulami, Zayed, et al.
Publicado: (2012)

In utero exposure to antidepressants and the use of drugs for pulmonary diseases in children
por: ter Horst, P. G. J., et al.
Publicado: (2012)

The role of Periodic Safety Update Reports in the safety management of biopharmaceuticals
por: Ebbers, Hans C., et al.
Publicado: (2012)

Intensive monitoring of duloxetine: results of a web-based intensive monitoring study
por: Härmark, Linda, et al.
Publicado: (2012)

Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and z-drugs consumption in nine European countries
por: Clay, Emilie, et al.
Publicado: (2012)

Role of pharmacoepidemiology studies in addressing pharmacovigilance questions: a case example of pancreatitis risk among ulcerative colitis patients using mesalazine
por: Russo, Leo, et al.
Publicado: (2014)

Reducing the noise in signal detection of adverse drug reactions by standardizing the background: a pilot study on analyses of proportional reporting ratios-by-therapeutic area
por: Grundmark, Birgitta, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_cm3rd4b1clir1vrvfjd6l5dpf0